CLMNT
ActiveSummary
CLMNT has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €591,093 and a net result of €295,931. Equity has been growing by about 96% per year since 2023. The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 17-08-2023 Normal situation
- Activity
- “Het beheren van een diagnosecentrum aan de artsen die in het kader van de…” (deed in Dutch)From the articles, 10 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.348.369.109 2460 Kasterlee, since 17-08-2023
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €394,043
- ▲ 8.4%
- Turnover
- ≈ €790,000
- estimated
- Profit
- €295,931
- ▲ 9.0%
- Equity
- €591,093
- ▲ 100%
- Total assets
- €685,439
- ▲ 75.0%
Filed on 03-04-2026, 119 days before the deadline
Score breakdownraises riskFounded in 2023lowers riskSize: total assets €685,439No main activity registeredLiquidity: current ratio 6.56, cash €121,195Show the evidence
Checked score
Score 2025
98
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 82% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency
100=
equity 86.2% of total assets
Liquidity
70-20
short-term debt 13.8% · cash 17.7%
Profitability
100=
return on assets 43.2%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 1.0%
01-2025: 1.0%● unchanged vs 12-2024
02-2025: 1.0%● unchanged vs 01-2025
03-2025: 1.0%● unchanged vs 02-2025
04-2025: 1.1%▲ +0.1 percentage points vs 03-2025
05-2025: 1.1%● unchanged vs 04-2025
06-2025: 1.1%● unchanged vs 05-2025
07-2025: 1.2%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.1%▼ -1.1 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026lowest value
07-2026: < 0.1%● unchanged vs 06-2026lowest value
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.56 (3.9 in 2024), above the usual 1.5. Short-term debt is 13.8% and cash 17.7% of total assets. 13.8% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 65% on liquidity, 90% on profitability and 92% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-04-2026, 119 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
119 days early
2024
21 days early
2023
22 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 3 accounts on average 54 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (3 of the last 3 accounts filed within 98 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 03-04-2026 PDF all 3 filings
Turnover
≈ €790,000
Estimated: probably between €550,000 and €1.1m
Total assets
€685,439▲ 75.0%
2024 · €391,633
Net result
€295,931▲ 9.0%
2024 · €271,579
Working capital
€523,896▲ 87.0%
2024 · €280,151
Trend over the years
2023 to 2025, 3 financial years
The operating result for 2025 is 8% higher than in 2024 and the highest since 2023. It is the second rise in a row.
Operating result€385,090
2025
Net result€295,931
2025
Total assets€685,439
2025
Equity€591,093
2025
Debt€94,346
2025
Working capital€523,896
2025
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
Use the arrow keys on the chart for the figures per year.
Every figure with its change against the financial year before
favourable
unfavourable
Line202320242025
Operating result€26,209-€356,789▲ 14×€385,090▲ 7.9%
Net result€20,582-€271,579▲ 13×€295,931▲ 9.0%
Equity€23,582-€295,162▲ 13×€591,093▲ 100%
Total assets€46,793-€391,633▲ 737%€685,439▲ 75.0%
Debt€23,211-€96,472▲ 316%€94,346▼ 2.2%
Working capital€6,109-€280,151▲ 46×€523,896▲ 87.0%
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €685,439
Fixed assets
€67,232 ▲ 348%
Current assets
€618,206 ▲ 64.1%
Equity and liabilities €685,439
Equity
€591,093 ▲ 100%
Debt
€94,346 ▼ 2.2%
Debt's share of the balance-sheet total falls from 24.6% to 13.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€393,858▲
2024 · €363,168
Cash flow
€304,699▲
2024 · €277,959
Current ratio
6.56▲
2024 · 3.90
Debt to equity
0.16▼
2024 · 0.33
ROE
50.1%▼
2024 · 92.0%
ROA
43.2%▼
2024 · 69.3%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€94,310▼
2024 · €96,472
Income taxes
€92,214▲
2024 · €85,166
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Tangible fixed assets | €19,000 | €3,917 | €66,229 |
| Depreciation and write-downs of the year | €1,527 | €6,379 | €8,767 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Companies with the same profile, two years later
Historical observationIn July 2024, 3,127 companies had the same profile as CLMNT has now. Two years later, 0.8% had gone bankrupt and 97.2% were still going.
- Small
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.8%
went bankrupt
1.9%
stopped otherwise
97.2%
was still going
That fits the bankruptcy probability of CLMNT itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,127 companies, not a prediction for CLMNT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Annual accounts
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €260 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,527 | €6,379 | €8,767 | ▲ 37.4% |
| Other operating charges640/8 | €422 | €182 | €186 | ▲ 2.1% |
| Gross operating margin9900 | €28,158 | €363,350 | €394,043 | ▲ 8.4% |
| Operating profit (loss)9901 | €26,209 | €356,789 | €385,090 | ▲ 7.9% |
| Financial income75/76B | - | - | €3,100 | - |
| Recurring financial income75 | - | - | €3,100 | - |
| Financial charges65/66B | €13 | €44 | €45 | ▲ 3.9% |
| Recurring financial charges65 | €13 | €44 | €45 | ▲ 3.9% |
| Profit (loss) for the period before taxes9903 | €26,196 | €356,745 | €388,145 | ▲ 8.8% |
| Income taxes67/77 | €5,614 | €85,166 | €92,214 | ▲ 8.3% |
| Profit (loss) for the period9904 | €20,582 | €271,579 | €295,931 | ▲ 9.0% |
| Profit (loss) for the period to be appropriated9905 | €20,582 | €271,579 | €295,931 | ▲ 9.0% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €46,793 | €391,633 | €685,439 | ▲ 75.0% |
| Fixed assets21/28 | €17,473 | €15,010 | €67,232 | ▲ 348% |
| Tangible fixed assets22/27 | €17,473 | €15,010 | €67,232 | ▲ 348% |
| Plant, machinery and equipment23 | - | - | €5,776 | - |
| Furniture and vehicles24 | €17,473 | €11,140 | €39,636 | ▲ 256% |
| Other tangible fixed assets26 | - | €3,871 | €21,821 | ▲ 464% |
| Current assets29/58 | €29,320 | €376,623 | €618,206 | ▲ 64.1% |
| Amounts receivable within one year40/41 | - | - | €97,012 | - |
| Trade receivables40 | - | - | €97,012 | - |
| Current investments50/53 | - | €200,000 | €400,000 | ▲ 100% |
| Cash at bank and in hand54/58 | €14,357 | €153,986 | €121,195 | ▼ 21.3% |
| Deferred charges and accrued income490/1 | €14,963 | €22,637 | €0 | ▼ 100% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €46,793 | €391,633 | €685,439 | ▲ 75.0% |
| Equity10/15 | €23,582 | €295,162 | €591,093 | ▲ 100% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | = |
| Reserves13 | €20,582 | €292,162 | €588,093 | ▲ 101% |
| Distributable reserves133 | €20,582 | €292,162 | €588,093 | ▲ 101% |
| Amounts payable17/49 | €23,211 | €96,472 | €94,346 | ▼ 2.2% |
| Amounts payable within one year42/48 | €23,211 | €96,472 | €94,310 | ▼ 2.2% |
| Trade debts44 | €154 | €363 | €0 | ▼ 100% |
| Suppliers440/4 | €154 | €363 | €0 | ▼ 100% |
| Taxes, remuneration and social security45 | €5,614 | €88,166 | €94,284 | ▲ 6.9% |
| Taxes450/3 | €5,614 | €88,166 | €94,284 | ▲ 6.9% |
| Other amounts payable47/48 | €17,443 | €7,943 | €26 | ▼ 99.7% |
| Accrued charges and deferred income492/3 | - | - | €36 | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €20,582 | €271,579 | €295,931 | ▲ 9.0% |
| + Depreciation and write-downs630 | €1,527 | €6,379 | €8,767 | ▲ 37.4% |
| Operating cash flow (approximation) | €22,109 | €277,959 | €304,699 | ▲ 9.6% |
| Investment in fixed assets (approximation) | - | -€3,917 | -€60,989 | ▼ 1,457% |
| Change in cash | - | €139,629 | -€32,791 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Board & ownership
Directors
Directors
1 director, no change since 2023
HUYSENTRUYT,Clément Julien Roland
Current
Director (not named in the articles) · appointed in the act of 21-08-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 03-04-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 21-08-2023Owners and capital
Shareholders
At incorporation
act of 21-08-2023 ↗
- HUYSENTRUYT,Clément Julien Roland 100 shares (100%) · €3,000 in cash
Capital transactions
Capital over time
- 21-08-2023 Incorporation · €3,000 · 100 shares
Articles of association
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten artikel 2:87 WVV zonder bijzondere machtiging, algemene vergadering kan te allen tijde bij gewone meerderheid beperken”
Articles of association, deed of 21-08-2023 (in Dutch)
Network & group
CLMNT shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of CLMNT. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
03-04
micro format · 119 days before the deadline
2025
31-12
Financial
Highest result from 2023 to 2025net €295,931 ▲9%
The operating result of €385,090 and the net result of €295,931 are both a record.
31-12
Financial
Equity above €500,000equity €591,093 ▲100%
With a profit in every financial year since 2023, equity grows to €591,093.
10-07
micro format · 21 days before the deadline
2024
31-12
Financial
Liquidity more than triplescurrent ratio 3.90
The current ratio rises from 1.26 to 3.90.
31-12
Financial
Equity above €200,000equity €295,162 ▲1,152%
With a profit in every financial year since 2023, equity grows to €295,162.
09-07
micro format · 22 days before the deadline
2023
21-08
Gazette deed
IncorporationStarting capital €3,000 · Appointment: HUYSENTRUYT,Clément Julien Roland (director) · Permanent representative: HUYSENTRUYT,Clément Julien Roland · Founder7 points ▸
Gazette deed
Incorporation
Starting capital €3,000 · Appointment: HUYSENTRUYT,Clément Julien Roland (director) · Permanent representative: HUYSENTRUYT,Clément Julien Roland · Founder7 points ▸
- Incorporation, 16-08-2023
- Founder, HUYSENTRUYT,Clément Julien Roland
- Registered office clause, “2460 Kasterlee(Lichtaart),Heuvelrand 37” (deed in Dutch)
- Founding capital, €3,000
- Board rule, 1
- Director appointment, HUYSENTRUYT,Clément Julien Roland (director (not named in the articles))
- Permanent representative, HUYSENTRUYT,Clément Julien Roland
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
CLMNT in Dutch
Enterprise number
0804.854.728
Legal form
Private limited company
Status
Active, normale toestand
Founded
17-08-2023
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 21-08-2023 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaamse Gewest, exploitatiezetels,administratieve zetels,filialen,agentschappen,depots in België of buitenland bij beslissing bestuursorgaan”
deed of 21-08-2023 (in Dutch)Registered office and establishments
Registered office
Heuvelrand 37, 2460 Kasterlee, Belgium
Establishment unit
CLMNT, Heuvelrand 37, 2460 Kasterlee since 17-08-2023 · unit number 2.348.369.10986220 Specialist medical practice
Activities
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 21-08-2023 (in Dutch)
“Het beheren van een diagnosecentrum aan de artsen die in het kader van de vennootschap werken, de aan- en verkoop, het huren en verhuren van…”
10 activities
- Het beheren van een diagnosecentrum aan de artsen die in het kader van de vennootschap werken, de aan- en verkoop, het huren en verhuren van gebouwen en materieel voor de uitoefening van het maatschappelijk voorwerp van de artsen-aandeelhouders, het ter beschikking stellen aan de artsen die in het kader van de vennootschap werken van medisch materieel en alles wat noodzakelijk is voor de uitoefening van de voormelde discipline, in het kort: alle materiële voorwaarden scheppen met het oog op het verstrekken van bedoelde geneeskundige zorgen.
- Het inrichten van algemene diensten en medisch secretariaten in het bijzonder, die nodig of nuttig zijn voor de uitoefening van voornoemde activiteiten.
- Het organiseren met seminaries, lessen, opleidingen, symposia, studiereizen en congressen in verband met de algemene geneeskunde of pathologische anatomie of aanverwante disciplines, evenwel zonder het voorwerp van de vennootschap aan te tasten.
- De aankoop, het huren en/of leasen van alle medische documentatie, apparatuur en begeleidende accommodaties, inclusief gebouwen, kortom van een volledige materiële infrastructuur, om deze terbeschikking te stellen van de arts-aandeelhouder of artsen-aandeelhouders.
- Het scheppen van mogelijkheden om de artsen-aandeelhouders toe te laten zich verder te bekwamen in voormelde medische discipline, dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken.
- Het ondernemen van alle verrichtingen van onroerende, roerende of financiële aard, die rechtstreeks met haar voorwerp verwant of verknocht zijn, of de verwezenlijking ervan kunnen bevorderen, met uitzondering van het afsluiten van overeenkomsten die ook artsen volgens de Geneeskundige Plichtenleer van de Orde van artsen niet mogen afsluiten met andere artsen of met derden.
- Het aanleggen van reserves, nodig tot het verschaffen van alle dienstige apparatuur, gebouwen en transportmiddelen noodzakelijk en bevorderlijk voor het uitoefenen van alle bovenvermelde beroepsactiviteiten door de arts-aandeelhouder(s) en zonder afbreuk te doen aan de Geneeskundige Plichtenleer, een bestemming te geven aan haar gereserveerde winsten van welke aard ook.
- Het leveren van diensten en het geven van advies met betrekking tot technieken voor moleculair biologische, histopathologische, morfologische, toxicologische en biochemische analyse van vochten en weefsels. Het geven van advies over de toepassing van deze technieken in het farmaceutisch en wetenschappelijk onderzoek. Het leveren van diensten en advies rond kwaliteitscontrole van laboratoria. Het leveren van diensten en advies rond automatisatie en management van laboratoria en onderzoeksprojecten.
- Het leveren van diensten en het geven van advies met betrekking tot het vertalen van medische teksten of vragenlijsten vanuit een andere taal naar het Nederlands.
- De vennootschap kan eveneens het beheer uitoefenen over hogervermelde roerende en onroerende goederen die haar toebehoren onder uitdrukkelijke voorwaarde evenwel dat ze het karakter van de vennootschap niet wijzigt en hierdoor in gene mate en op geen enkel ogenblik aanleiding heeft tot het ontwikkelen van welke commerciële activiteit ook.
Invoicing and payment
VAT number
BE 0804.854.728
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Thursday of June at 18:00
deed of 21-08-2023 (in Dutch)Sites & property
Location
Buildings and parcels at the address
Ground area
794 m²
Building footprint
164 m²
Building volume
20 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 13018C0380/00D003 | Flanders | 794 m² | 1 · 164 m² | 2.7 m |